Asthma Control Can Be Maintained after Fixed-Dose, Budesonide/Formoterol Combination Inhaler Therapy is Stepped Down from Medium to Low Dose

Asthma Control Can Be Maintained after Fixed-Dose, Budesonide/Formoterol Combination Inhaler Therapy is Stepped Down from Medium to Low Dose

Background: In cases using a budesonide/formoterol combination inhaler, many patients are started on fixed-dose treatment at 640/18 μg (4 puffs) daily, but there are no guidelines yet regarding the step-down method when control has been maintained. Methods: Patients with moderate asthma treated with...

Full description

Bibliographic Details
Main Authors:	Masayuki Hojo, Tomonori Mizutani, Motoyasu Iikura, Satoshi Hirano, Nobuyuki Kobayashi, Haruhito Sugiyama
Format:	Article
Language:	English
Published:	Elsevier 2013-01-01
Series:	Allergology International
Subjects:	asthma Asthma Control Test budesonide/formoterol combination inhaler fractional exhaled nitric oxide (FeNO) step down
Online Access:	http://www.sciencedirect.com/science/article/pii/S132389301530112X

Similar Items

A Comparison of Long-Term Anti-Inflammatory Effect of Two ICS/LABA Combination Inhalers; Fix-Dosed Maintenance Therapy with Budesonide/Formoterol and Salmeterol/Fluticasone
by: Masayuki Hojo, et al.
Published: (2014-01-01)

Exposure-Response and Clinical Outcome Modeling of Inhaled Budesonide/Formoterol Combination in Asthma Patients
by: Hyun-moon Back, et al.
Published: (2020-04-01)

Adherence and quality of life assessment in patients with asthma treatment with budesonide/formoterol via the Elpenhaler device: the COMPLETE study
by: Konstantinos P. Exarchos, et al.
Published: (2022-06-01)

The cost-effectiveness of as-needed budesonide-formoterol versus low-dose inhaled corticosteroid maintenance therapy in patients with mild asthma in Canada
by: Mohsen Sadatsafavi, et al.
Published: (2021-10-01)

Comparison of efficacy between long-acting beta 2-agonists (formoterol fumarate) and leukotriene-receptor antagonists (montelukast) as add-on therapy to inhaled corticosteroids (budesonide) in moderate persistent asthma
by: Sasikala Kumaravel, et al.
Published: (2014-01-01)

Some aspects of application of the combination of formoterol and budesonide: what is changed?
by: A. A. Vizel, et al.
Published: (2019-12-01)

Efficacy of budesonide/glycopyrronium/formoterol metered dose inhaler in patients with COPD: post-hoc analysis from the KRONOS study excluding patients with airway reversibility and high eosinophil counts
by: Shigeo Muro, et al.
Published: (2021-06-01)

Evaluation of inhaler technique and achievement and maintenance of mastery of budesonide/formoterol Spiromax® compared with budesonide/formoterol Turbuhaler® in adult patients with asthma: the Easy Low Instruction Over Time (ELIOT) study
by: David B. Price, et al.
Published: (2018-06-01)

An individualized, adjustable maintenance regimen of budesonide/formoterol provides effective asthma symptom control at a lower overall dose than fixed dosing
by: L Meyer, et al.
Published: (2003-05-01)

Effect of Switching from Salmeterol/Fluticasone to Formoterol/Budesonide Combinations in Patients with Uncontrolled Asthma
by: Taisuke Akamatsu, et al.
Published: (2012-01-01)

Inhaled budesonide for adults with mild-to-moderate asthma: a randomized placebo-controlled, double-blind clinical trial
by: Ana Luisa Godoy Fernandes, et al.
Published: (2001-09-01)

Triple Therapy with Budesonide/Glycopyrrolate/Formoterol Fumarate Improves Inspiratory Capacity in Patients with Asthma-Chronic Obstructive Pulmonary Disease Overlap
by: Ishiura Y, et al.
Published: (2020-02-01)

Bronchodilatory effect of inhaled budesonide/formoterol and budesonide/salbutamol in acute asthma: a double-blind, randomized controlled trial
by: Arun Jenish J, et al.
Published: (2012-03-01)

Effects of treatment with montelukast alone, budesonide/formoterol alone and a combination of both in cough variant asthma
by: Fang Yi, et al.
Published: (2022-10-01)

Successful Sequential Treatment for Severe Asthma Coexisting COVID-19 via Budesonide/Glycopyrrolate/Formoterol Fumarate
by: Liang Y, et al.
Published: (2021-02-01)

Pharmacoeconomics analysis of using a fixed combination of budesonide/formoterol in patients with asthma in the health care system of the Russian Federation
by: Sergey K. Zyryanov, et al.
Published: (2022-08-01)

Effectiveness and Patient Satisfaction with Budesonide/Formoterol Easyhaler® Among Patients with Asthma or COPD Switching from Previous Treatment: a Real-World Study of Patient-Reported Outcomes
by: Gabriella Gálffy, et al.
Published: (2019-07-01)

A scintigraphy study of budesonide/glycopyrrolate/formoterol fumarate metered dose inhaler in patients with moderate-to-very severe chronic obstructive pulmonary disease
by: Omar Usmani, et al.
Published: (2021-10-01)

EXPERIENCE OF LONG-TERM USE OF SYMBICORT IN THE REGIME OF A SIGNLE INHALER FOR BRONCHIAL ASTHMA, INCLUDING DURING PREGNANCY
by: I. I. VORZHEVA
Published: (2016-12-01)

Is It Really Feasible to Use Budesonide–Formoterol as Needed for Mild Persistent Asthma? A Systematic Review and Meta-Analysis
by: Xiang Tong, et al.
Published: (2021-06-01)

A Pilot Randomized Trial of As-Needed Budesonide-Formoterol for Stepping Down Controller Treatment in Moderate Asthma with Complete Remission
by: Narongwit Nakwan, et al.
Published: (2022-07-01)

Metabolic changes of different high-resolution computed tomography phenotypes of COPD after budesonide–formoterol treatment
by: Wang C, et al.
Published: (2017-12-01)

Eficácia do formoterol na reversão imediata do broncoespasmo Efficacy of inhaled formoterol in reversing bronchoconstriction
by: Adalberto Sperb Rubin, et al.
Published: (2006-06-01)

Therapeutic drug monitoring of corticosteroids/β2-agonists in the hair of patients with asthma: an open-label feasibility study
by: Hélène Salvator, et al.
Published: (2024-01-01)

Rational therapy of asthma in children with inhaled corticosteroids
by: N. A. Geppe, et al.
Published: (2016-12-01)

Clinical experience of using formoterol/budesonide in patients with chronic obstructive pulmonary disease
by: I. V. Demko, et al.
Published: (2021-10-01)

Cost-utility of as-needed ICS-formoterol versus to maintenance ICS in mild to moderate persistent asthma
by: Jefferson Antonio Buendía, et al.
Published: (2021-12-01)

Effectiveness of budesonide formoterol fixed-dose combination MDI in reducing cough symptoms in COVID-19 patients: A real-world evidence study
by: Shambo Samrat Samajdar, et al.
Published: (2023-01-01)

Comparison of the effectiveness and safety of formoterol versus salmeterol in the treatment of patients with asthma: A systematic review and meta-analysis
by: Ashraf Velayati, et al.
Published: (2015-01-01)

Quantitative CT Metrics for the Prediction of Therapeutic Effect in Asthma
by: Donghai Ma, et al.
Published: (2023-01-01)

BRONCHIAL ASTHMA THERAPY IN SMART-REGIME: STUDIES IN REAL CLINICAL PRACTICE
by: R. S. FASSAKHOV
Published: (2016-12-01)

Mild bronchial asthma: a modern treatment concept
by: A. V. Emel’yanov, et al.
Published: (2019-12-01)

Exacerbations and Real-World Outcomes After Single-Inhaler Triple Therapy of Budesonide/Glycopyrrolate/Formoterol Fumarate, Among Patients with COPD: Results from the EROS (US) Study
by: Strange C, et al.
Published: (2023-10-01)

Risks of budesonide/formoterol for the treatment of stable COPD: a meta-analysis
by: Tang B, et al.
Published: (2019-04-01)

Inhalation of Budesonide/Formoterol Increases Diaphragm Muscle Contractility
by: Chiyohiko Shindoh, et al.
Published: (2012-01-01)

Knowledge of fractional exhaled nitric oxide use among doctors working in a local respiratory department
by: Etienne Ceci Bonello, et al.
Published: (2023-02-01)

Response to Omalizumab as an Add-On Therapy in the Treatment of Allergic Asthma in Adult Chinese Patients—A Retrospective Study
by: Na Li, et al.
Published: (2022-12-01)

Managing pollen asthma with a single inhaler: a case study
by: N. M. Nenasheva
Published: (2015-12-01)

Effect of Inhaled Budesonide on Interleukin-4 and Interleukin-6 in Exhaled Breath Condensate of Asthmatic Patients
by: Chun-Hua Chi, et al.
Published: (2016-01-01)

Comparison of Rapid Bronchodilatory Effects of Salmeterol and Formoterol in Patients with Moderate to Severe Asthma
by: Ebrahim Salehifar, et al.
Published: (2015-10-01)